Device Trial Radar · NCT02138110
The INSPIRE Study: Probable Benefit of the Neuro-Spinal Scaffold for Treatment of AIS A Thoracic Acute Spinal Cord Injury
Last checked: Nov 20, 2026Latest source record: Jan 17, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
20
Actual
Start
Oct 13, 2014
Primary completion
Nov 29, 2017
Study completion Dec 2023
Sponsor
- Lead sponsor
- InVivo TherapeuticsNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 14, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 16 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an HDE probable benefit, open-label, non- randomized, single-arm, multicenter study to evaluate the safety and probable benefit of the poly(lactic-co-glycolic acid)-b-poly(L-lysine) Scaffold ("Scaffold") in subjects with thoracic AIS A traumatic spinal cord injury at neurological level of injury of T2-T12.
Conditions
- Traumatic Thoracic Acute Spinal Cord Injury
Interventions
Neuro-Spinal ScaffoldDevice
Implantation of a Neuro-Spinal Scaffold into the epicenter of the post-irrigation contusion cavity during open spine surgery
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Patients With Improvement in AIS Grade of One or More LevelsTime frame: 6 months post-implantation
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
Barrow Neurological Institute - St. Joseph's Hospital and Medical Center
Phoenix, Arizona
7 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.